Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of SC Abatacept in Healthy Chinese Subjects
NCT02805010Phase 1Unknown
- Sponsor
- Simcere Pharmaceutical Group
- Start
- Oct 2016
- Primary completion
- Feb 2017
- Modality
- Fc-Fusion Proteins
01
Overview
Phase 1, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Abatacept SC with Placebo SC (2 arms). Primary endpoints: Maximum Plasma Concentration, Area Under the Curve and 2 more. Status: unknown.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02805010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02805010.